You have found the medication that finally works. Your depression is in remission, or your anxiety is manageable for the first time in years. And now you want to become pregnant — which means you are facing one of the most emotionally charged questions in psychiatry: What do I do about my medication?
You may have already spent hours on the internet, cycling through alarm and reassurance, walking away more confused than when you started. You may have a well-meaning OB who told you to “just stop” before trying to conceive, or a primary care doctor who is uncertain what to advise. You may have made the decision on your own — tapering quietly, hoping for the best — and found yourself in a frightening relapse that nobody had prepared you for.
This guide is written for you. Its purpose is not to tell you that medication is safe or that it is dangerous. The honest answer is that both the medication and the untreated illness carry risk, and which risk is greater depends entirely on your individual history, your diagnosis, and the specific medication you take. What this guide will do is give you the clinical framework that a reproductive psychiatrist uses — so that you can walk into your consultation informed, ask the right questions, and stop trying to make a high-stakes medical decision from a Google search.
At Massachusetts Psychiatry, led by Dr. Sophia Maurasse, MD, we provide specialized preconception psychiatric evaluations and perinatal mental health care for women across Massachusetts, including Boston and surrounding communities statewide through telepsychiatry. What follows is the evidence-based foundation for that care.
Why Psychiatric Medication Planning Before Pregnancy Matters
The single most dangerous thing a woman can do when planning a pregnancy while on psychiatric medication is to make an abrupt, unplanned medication change without the guidance of a psychiatrist. Yet it happens constantly — often because the patient fears judgment, cannot access a specialist, or simply does not know that preconception psychiatric planning is a defined clinical service.
The reason timing matters so profoundly comes down to a convergence of biology and timing. The first trimester is the period of greatest fetal organ development and simultaneously the period of highest vulnerability for psychiatric relapse in women who have recently discontinued medication. The worst possible scenario — a psychiatric crisis during the first twelve weeks of pregnancy — is also one of the most preventable with adequate advance planning.
The Relapse Risk of Stopping Medication Abruptly
Research on antidepressant discontinuation in pregnancy planning is unambiguous on one point: abrupt or rapid discontinuation dramatically increases relapse risk. A landmark prospective study published in JAMA found that women with histories of depression who discontinued antidepressants during preconception or early pregnancy were more than five times more likely to relapse than those who maintained their medication. That relapse typically occurred in the first trimester — precisely when many women do not yet know they are pregnant and are least equipped to restart treatment quickly.
This does not mean medication should never be discontinued before or during pregnancy. For some patients, a carefully planned, gradual discontinuation completed well in advance of conception — with confirmed stability before trying to conceive — is the right clinical architecture. What the evidence argues against is an unplanned taper, initiated without psychiatric guidance, compressed to meet an ovulation calendar.
The Importance of Preconception Planning
Reproductive psychiatry guidelines from both the American College of Obstetricians and Gynecologists (ACOG) and the American Psychiatric Association (APA) recommend that women on psychiatric medication seek preconception counseling before attempting to conceive. This consultation serves several critical functions:
- Full psychiatric history review to stratify relapse risk
- Evaluation of current medications for pregnancy safety data
- Discussion of medication continuation, dose adjustment, or transition to agents with stronger safety profiles
- Coordination with obstetric care providers
- Baseline documentation so that the postpartum period — a time of very high relapse risk — is planned for in advance
The OB-GYN and Psychiatrist Partnership
Optimal perinatal psychiatric care requires coordinated communication between the patient’s obstetrician and psychiatrist. These providers bring complementary expertise: the OB monitors fetal development and pregnancy physiology, while the psychiatrist manages medication dosing, monitors psychiatric stability, and adjusts treatment as the physiologic changes of pregnancy alter medication metabolism. Pregnancy significantly changes the pharmacokinetics of many psychiatric medications — blood volume increases, renal clearance accelerates, and hepatic enzyme activity shifts — meaning that a dose that provided stability before pregnancy may be inadequate at 28 weeks.
Comprehensive Mental Healthcare Services
Massachusetts Psychiatry offer various therapeutic services to support your mental and emotional wellbeing.
Are Psychiatric Medications Safe During Pregnancy?
This is the question every patient asks, and it deserves a careful, honest answer rather than either categorical alarm or false reassurance. The truthful answer is: it depends on the specific medication, the specific condition, the trimester, and the individual patient. What the body of evidence does support — clearly, across decades of research — is that the medications most commonly used in psychiatric treatment are not blanket contraindications to pregnancy.
1 in 7
Women experience depression during pregnancy or the postpartum period
70%
Rate of relapse in women who discontinue antidepressants abruptly before conception
5×
Higher relapse risk for women who stop antidepressants vs. those who continue (JAMA)
50%
Of perinatal mental health cases go undiagnosed without proactive screening
SSRIs (Selective Serotonin Reuptake Inhibitors)
SSRIs are the most studied class of psychiatric medication in pregnancy, with decades of safety data accumulated across hundreds of thousands of pregnancies. Medications such as sertraline and fluoxetine have extensive reproductive safety profiles. The largest and most methodologically rigorous studies — those that control for the confounding effect of the underlying maternal illness itself — find no causal link between SSRI exposure and neurodevelopmental disorders in children. Certain early studies suggesting risk were conducted without this confound control, leading to findings that did not replicate in better-designed research.
One signal that warrants discussion is the association between third-trimester SSRI exposure and neonatal adaptation syndrome (NAS) — a transient condition in some newborns characterized by tremulousness, feeding difficulty, and mild respiratory changes that typically resolves within days without lasting effects. This is an important consideration in birth planning, not a reason to discontinue medication without careful individualized analysis.
There is also a small signal for persistent pulmonary hypertension of the newborn (PPHN) with late-pregnancy SSRI use. The absolute risk, even if real, is low — but it is one of the considerations a reproductive psychiatrist weighs.
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
SNRIs such as venlafaxine and duloxetine have a shorter reproductive evidence base than SSRIs but an expanding one. Current data are generally reassuring, with patterns similar to SSRIs regarding NAS in the third trimester. For women already stable on an SNRI, switching to an SSRI solely for pregnancy is often not indicated and can itself carry relapse risk.
Mood Stabilizers
This category requires the most individualized discussion, because the medications vary significantly in their risk profiles and the conditions they treat carry high relapse stakes.
Lithium was historically associated with cardiac malformations (Ebstein’s anomaly), but more recent and larger cohort studies substantially revised this risk estimate downward. The absolute risk, if real, is much smaller than once believed. For women with bipolar I disorder — where lithium is often the most effective and stabilizing agent — the risk of untreated bipolar relapse in pregnancy, including manic episodes with impulsive behavior and severe depressive episodes with suicidality, frequently outweighs the medication risk.
Valproate (Depakote) has the most significant reproductive safety concerns of the commonly used mood stabilizers, including neural tube defects and neurodevelopmental effects at higher doses. It is generally avoided in pregnancy where alternatives exist, and women of reproductive age on valproate should have an explicit preconception conversation about contraception and alternatives.
Lamotrigine (Lamictal) has a more favorable reproductive safety profile among mood stabilizers and is often a preferred agent for bipolar patients in the perinatal period. It requires careful dose monitoring in pregnancy, as pregnancy significantly accelerates its metabolism and doses often need substantial upward adjustment to maintain effectiveness.
Benzodiazepines and Anxiolytics
Benzodiazepines carry specific considerations in pregnancy, including potential associations with preterm birth and neonatal withdrawal, particularly with regular use. For anxiety management in pregnancy, non-benzodiazepine approaches — SSRIs, psychotherapy, and evidence-based behavioral interventions — are generally preferred. Short-term, low-dose, situational use may be considered in specific clinical contexts under close psychiatric supervision.
Atypical Antipsychotics
Second-generation antipsychotics are used in bipolar disorder, treatment-resistant depression, and psychotic conditions. Reproductive safety data varies by agent, with quetiapine, olanzapine, and aripiprazole having the most accumulated data. Metabolic monitoring during pregnancy is important for patients on these agents.
Common Mental Health Conditions During Pregnancy
Pregnancy does not protect against psychiatric illness. In fact, the profound hormonal, physiological, and psychological changes of the perinatal period can unmask latent vulnerabilities, worsen existing conditions, or trigger new ones. Understanding how each condition behaves in the perinatal context is essential to individualized care.
Depression During Pregnancy
Prenatal depression is significantly underdiagnosed, partly because its symptoms — fatigue, sleep changes, appetite shifts, reduced motivation — overlap substantially with normal pregnancy experiences. Yet it is not a minor clinical concern. Untreated prenatal depression is one of the strongest predictors of postpartum depression, and its physiological effects on the pregnancy — via stress hormones, disrupted sleep, nutritional neglect, and reduced prenatal care engagement — are well-documented in the obstetric literature.
Anxiety Disorders During Pregnancy
Anxiety disorders are the most common psychiatric conditions in the perinatal period, yet they are often minimized with reassurances like “it’s normal to be anxious during pregnancy.” While some degree of worry is universal, clinical anxiety disorder is a distinct condition requiring treatment. Chronic, uncontrolled anxiety maintains a persistent state of physiological stress arousal that — via the maternal hypothalamic-pituitary-adrenal axis — is transmitted to the intrauterine environment. For women with pre-existing anxiety disorders, pregnancy can intensify symptom burden rather than alleviate it.
Bipolar Disorder During Pregnancy
Bipolar disorder carries the highest stakes in the perinatal period of any commonly treated psychiatric condition. The postpartum period is the time of greatest lifetime risk for a bipolar episode, and postpartum psychosis — a psychiatric emergency — occurs in up to one in four women with bipolar I who deliver without prophylactic treatment. Preconception planning for a patient with bipolar disorder is not optional; it is a clinical necessity. The conversation must include which mood stabilizer offers the best efficacy-to-risk ratio for pregnancy, how to manage the postpartum high-risk window, and what monitoring is required through delivery.
PTSD During Pregnancy
Trauma history intersects with pregnancy in complex ways. Obstetric examinations, physical vulnerability, loss of bodily autonomy, and fear of the birthing process can all activate trauma responses. Women with PTSD who are planning pregnancy benefit from proactive treatment — both psychotherapy (particularly Trauma-Focused CBT and EMDR) and, where indicated, medication management — well before conception.
Perinatal OCD
OCD in the perinatal period often takes a distinctive form: intrusive, ego-dystonic thoughts about harming the infant. These thoughts — which are profoundly distressing to the mother and entirely inconsistent with her actual intentions — are frequently misidentified by non-specialist providers as indicators of psychosis or dangerous behavior. Perinatal OCD is a treatable condition; its misidentification leads to inadequate treatment and significant unnecessary suffering. SSRIs remain first-line pharmacologic treatment, and Exposure and Response Prevention (ERP) therapy is highly effective.
The Risks of Untreated Mental Illness During Pregnancy vs. Medication
The conversation about psychiatric medication in pregnancy is almost always framed as “medication risk vs. no medication.” This framing is clinically inaccurate. The correct comparison is medication risk vs. untreated illness risk. Both carry risks. A balanced decision requires considering both sides of that equation.
What Untreated Depression and Anxiety Actually Do
The obstetric consequences of untreated maternal depression and anxiety are well-documented and include:
- Preterm birth — untreated depression is associated with approximately 1.5 times the background risk of preterm delivery
- Low birth weight — associated with roughly a two-fold increase in risk in severe untreated depression
- Reduced prenatal care engagement — missed appointments, inadequate nutrition, reduced folic acid compliance
- Increased substance use risk — alcohol and tobacco use in untreated psychiatric illness compound fetal risk
- Elevated suicide risk — pregnancy does not confer protection against suicidality in severe psychiatric illness; suicide is a leading cause of maternal mortality
- High postpartum depression risk — prenatal depression is the single strongest predictor of postpartum depression
- Disrupted maternal-infant bonding — untreated postpartum illness impairs the early bonding process with documented long-term neurodevelopmental consequences for the child
Safe Treatment Approaches During Pregnancy
Psychiatric care during pregnancy is not limited to medication. A comprehensive perinatal mental health plan integrates multiple treatment modalities, calibrated to the patient’s diagnosis, symptom severity, and personal preferences.
Medication Management During Pregnancy
For patients who continue psychiatric medication during pregnancy, active medication management — not passive prescription continuation — is essential. Pregnancy significantly alters medication pharmacokinetics. Blood volume expands by 40–50%, renal clearance accelerates, and hepatic enzyme activity shifts, all of which can reduce effective medication levels. A patient who was stable on a given dose before pregnancy may become under-medicated during the second or third trimester without a dose adjustment.
At Massachusetts Psychiatry, medication management during pregnancy includes monitoring for symptom breakthrough, dose adjustments where indicated, communication with the obstetric team around delivery planning, and a postpartum medication plan established before delivery — not scrambled together in the first sleep-deprived days after birth.
Psychotherapy Options During Pregnancy
For some patients — particularly those with mild to moderate depression or anxiety, or those who choose to discontinue medication — evidence-based psychotherapy is a primary treatment modality during pregnancy. Effective options include:
- Cognitive Behavioral Therapy (CBT) — The most extensively studied psychotherapy for perinatal depression and anxiety, with strong evidence for efficacy. Addresses unhelpful thought patterns and behavioral cycles that maintain mood disorders.
- Interpersonal Therapy (IPT) — Specifically developed and validated for perinatal depression. Focuses on role transitions, grief, and relationship changes that are particularly salient in the transition to parenthood.
- Supportive Therapy — Provides validation, psychoeducation, and problem-solving in a structured therapeutic relationship, appropriate across diagnoses and severity levels.
- Mindfulness-Based Cognitive Therapy (MBCT) — Evidence-based for depression relapse prevention and particularly valuable for patients with recurrent depressive episodes.
Lifestyle and Non-Pharmacologic Interventions
Adjunctive interventions that have evidence for supporting mental health during pregnancy include structured aerobic exercise (which has demonstrated antidepressant effects comparable to medication in mild-to-moderate depression), sleep hygiene optimization, nutritional support including omega-3 fatty acids, and social support structures. These are genuine clinical interventions — not alternatives to treatment, but meaningful contributors to a comprehensive plan.
Telepsychiatry in Massachusetts
Geographic access to reproductive psychiatry specialists has historically been a barrier, particularly outside major metropolitan centers. Massachusetts Psychiatry offers telepsychiatry services across Massachusetts, providing patients from Boston, Worcester, Springfield, Cape Cod, Western Massachusetts, and the North and South Shores with access to board-certified psychiatric care without the burden of travel. Telepsychiatry is particularly valuable during pregnancy, when fatigue, physical discomfort, and scheduling complexity can make in-person appointments difficult to sustain.
Frequently Asked Questions
Should I stop my antidepressant before trying to get pregnant?
Not without consulting a psychiatrist first. For many women, continuing an antidepressant during pregnancy is safer than stopping. The key factors — your specific medication, your psychiatric history, your relapse history, and your planned timeline — require individualized evaluation to determine the right approach. Abrupt discontinuation is associated with high relapse risk, and a relapse in the first trimester is among the most difficult clinical scenarios to manage.
Is it safe to take SSRIs during pregnancy?
SSRIs are the most studied class of psychiatric medication in pregnancy, with decades of accumulated safety data. After controlling for the confounding effects of the underlying psychiatric illness, large-scale studies do not support a causal link between SSRI exposure and neurodevelopmental harm. There are specific considerations — including neonatal adaptation syndrome with third-trimester use — that are part of every individual risk-benefit discussion. The right answer for any individual patient depends on her specific SSRI, dose, diagnosis, and history.
What is perinatal psychiatry, and do I need it?
Perinatal psychiatry is the subspecialty of psychiatry focused on mental health care across the preconception, pregnancy, and postpartum continuum. It addresses psychiatric medication safety in pregnancy, diagnosis and treatment of perinatal mood and anxiety disorders, and individualized care planning for the high-risk period around delivery. If you have a psychiatric condition or are on psychiatric medication and are planning pregnancy, a perinatal psychiatrist is the most appropriate specialist to guide your treatment decisions.
Does Massachusetts Psychiatry offer telepsychiatry for pregnancy planning?
Yes. We provide telepsychiatry services across Massachusetts, allowing patients throughout the state — including those outside Boston and the Greater Boston area — to access preconception psychiatric consultations and perinatal mental health care remotely. Telepsychiatry is fully available for medication management, psychotherapy referral coordination, and ongoing monitoring throughout pregnancy and the postpartum period.
What are the risks of untreated depression during pregnancy?
Untreated depression during pregnancy is associated with increased risk of preterm birth, low birth weight, poor maternal nutrition, reduced prenatal care engagement, increased substance use risk, and postpartum depression. Suicide remains a leading cause of maternal mortality, particularly in untreated severe psychiatric illness. Treating maternal mental health is not a secondary concern — it is a direct contributor to birth outcomes and infant well-being.
How far in advance should I see a psychiatrist before trying to conceive?
Ideally, at least three to six months before you plan to begin trying. This timeline allows adequate runway for medication review, any planned transitions, confirmation of stability, and OB-GYN coordination. For patients on medications with specific preconception considerations — such as valproate, which requires contraceptive planning and careful transition — even earlier consultation is appropriate.
Can I see a psychiatrist in Massachusetts for pregnancy planning via telehealth?
Yes. Massachusetts Psychiatry offers telehealth psychiatric services statewide, including preconception counseling, medication management during pregnancy, and perinatal mental health evaluation. Patients across Massachusetts — including those in rural communities, the North Shore, South Shore, Western Massachusetts, and the Cape — can access board-certified psychiatric care without traveling to Boston.
TESTIMONIALS
In Their Own Words
JOIN THE COMMUNITY
Ready to Plan Your Pregnancy with Confidence?
If you are planning pregnancy and currently taking psychiatric medication — or if you have a history of depression, anxiety, or bipolar disorder and are thinking about starting a family — a preconception consultation at Massachusetts Psychiatry is the right first step. We help you build a treatment plan that protects your mental health and supports a healthy pregnancy, before and after conception.
- Massachusetts Psychiatry
- 68 Harrison Ave Ste 605, Boston, MA 02111, United States
- (617) 564-0654